A simplified method for the preparation of EAC14 intermediate cells using human serum treated with methylprednisolone.
The inhibitory effect of methylprednisolone 21-succinate ester (MPS) on the activities of complement components in human serum was studied by incubating human serum with various concentrations of MPS at 37 degrees C for 30 min and then measuring the residual activity of each component in human serum. The formation of EAC1 and EAC14 by C1 and C4 respectively, were only weakly inhibited by MPS at a final concentration of 10 mg/ml. In contrast, the same concentration of MPS completely inhibited the capacity of C2, C3, C5 and C6-9 to induce respective succeeding intermediates. On the basis of these findings a simplified method was devised for the preparation of EAC14 intermediates using human serum pretreated with MPS.
D000818:Animals; D003172:Complement C1 / Q000276:immunology*; D003181:Complement C4 / Q000276:immunology*; D003169:Complement Inactivator Proteins / Q000494:pharmacology; D003171:Complement Pathway, Classical / Q000187:drug effects; D003165:Complement System Proteins / Q000276:immunology*; D004912:Erythrocytes / Q000276:immunology*; D006801:Humans; D008775:Methylprednisolone / Q000031:analogs & derivatives*; D008776:Methylprednisolone Hemisuccinate / Q000494:pharmacology*; D012756:Sheep / Q000097:blood
D003172:Complement C1; D003181:Complement C4; D003169:Complement Inactivator Proteins; D008776:Methylprednisolone Hemisuccinate; D003165:Complement System Proteins; D008775:Methylprednisolone